This course has expired. You can still review the content but course credit is no longer available.
Rebecca T. Hahn, MD, FACC, FESC, hosts this webinar detailing the risk factors for prosthesis-patient mismatch (PPM) and reviews the best approach for each patient. Dr. Hahn also reviews in-depth the differences in outcomes, particularly in terms of mortality, between PPM after transcatheter aortic valve replacement versus surgical aortic valve replacement, and shares her clinical insight related to the optimal techniques for accurately assessing the incidence and severity of PPM.
At the conclusion of her presentation, there will be a live question and answer session with Dr. Hahn.
Supported by an independent educational grant from Edwards Lifesciences.
At the completion of this educational activity, you will be better able to:
Provided by Evolve Medical Education
Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Evolve designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS
Recommended internet speed 5Mbps+
Rebecca T. Hahn, MD, FACC, FESC
Professor of Medicine
Columbia University Medical Center
New York, NY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Rebecca T. Hahn, and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Speaker’s Bureau: Abbott Vascular, GE Medical, Philips Healthcare, and Boston Scientific. Consultant: 3Mensio, Abbott Vascular, Edwards Lifescience Medtronic, St. Jude Medical, Gore&Associates, Navigate, Philips Healthcare, and Siemens Healthineers.
The Evolve staff and planners have no financial relationships with commercial interests. Issam Moussa, MD, peer reviewer has no financial relationships with commercial interests.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Edwards Lifesciences.